Your initial consultation is free and allows your P3 clinician to truly understand your concerns and your goals
Most patients experience mild, temporary gastrointestinal side effects including nausea, vomiting, constipation, or diarrhea during the first 2-4 weeks as the body adjusts to hormone activationthese typically resolve as tolerance builds
A 40-unit dose falls well within the tested therapeutic range and produced average weight loss of 20% or more in trial participants
doi: 10.1038/nature22350 20 PeyronCTigheDKvan den PolANde LeceaLHellerHCSutcliffeJGet al
It can't reduce inflammation without the right fuel
New England Journal of Medicine, March 2023 In this Perspective piece, researchers at Vanderbilt University create a series of estimates about how much Medicare may have to spend annually on weight-loss drugs if the program eventually covers these drugs